UNSPSC 51294515: Azaloxan

This classification denotes an antidepressant agent with the molecular formula C18H25N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O653FA999, chemically known as (s)-1-(1-(2-(1,4-benzodioxan-2-yl)-ethyl)-4-piperidyl)-2-imidazolidinone but generally known as azaloxan fumarate, which bears US NIH Compound Identifier 6328465. European Medicines Agency schedules azaloxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05631MIG. Most nations schedule azaloxan under HS 29349990 and SITC 51579.

As of Q4 2014, AZALOXAN remains the US FDA Preferred Term for this commodity. Azaloxan bears US NLM identifiers UMLS ID C2698285 and NCI Concept Code C75051. SMILES: C1CN(CCC1N2CCNC2=O)CCC3COC4=CC=CC=C4O3.

UNSPSC 51294515 Azaloxan is a Commodity code that covers pharmaceutical products used in emergency response and harm-reduction initiatives. State and local governments procure naloxone and related drug-deactivation systems under this code to support community health and overdose-prevention programs. The work involves sourcing finished pharmaceutical products and medical systems for ongoing inventory and distribution to public health facilities, rather than manufacturing, research, or clinical services. Issuing bodies include county health departments and community health agencies responsible for emergency preparedness and public wellness initiatives.

Seminole County, Florida represents the primary recent activity under the code. The county issued IFB 60459723LAS on June 30, 2026, seeking procurement of 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The initial contract term runs two years with a one-year renewal option; bidders must include all shipping and delivery costs in their proposals, maintain workers' compensation and general liability insurance, comply with E-Verify requirements, and hold drug-free workplace certification. The procurement was potentially funded through FEMA, introducing federal compliance obligations around environmental regulations and audit requirements. No explicit small-business set-asides or disadvantaged-enterprise preferences were specified in the solicitation.